Nitrogen + Oxygen Compounds (N + O)
Found 698,656 compounds containing Nitrogen + Oxygen. Page 732 of 13974.
N
Nitrogen
78% of atmosphere
O
Oxygen
Essential for respiration
| Formula | IUPAC Name | Common Name | Mol. Weight |
|---|---|---|---|
| C18H25N3O | 4,6-dimethyl-2-(6-phenylhexylamino)pyrimidin-5-ol | enazadrem | 299.40 |
| C12H11N5O | 2-amino-7-(3-pyridylmethyl)-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one | 2-amino-7-(3-pyridylmethyl)-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one | 241.25 |
| C30H41N3O6 | [3-[[4-(2-isopropoxyphenyl)piperazin-1-yl]methyl]phenyl]-(1-piperidyl)methanone;succinic acid | MAZAPERTINE SUCCINATE | 539.70 |
| C26H35N3O2 | [3-[[4-(2-isopropoxyphenyl)piperazin-1-yl]methyl]phenyl]-(1-piperidyl)methanone | Mazapertine | 421.60 |
| C66H68CaF2N4O10 | calcium bis((3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoate) | ATORVASTATIN CALCIUM | 1155.30 |
| C33H35FN2O5 | (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid | atorvastatin | 558.60 |
| C15H18F3NO5 | (5R)-5-(methoxymethyl)-3-[4-[(3R)-4,4,4-trifluoro-3-hydroxy-butoxy]phenyl]oxazolidin-2-one | BEFLOXATONE | 349.30 |
| C8H11N3O3S | 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one | lamivudine | 229.26 |
| C14H7ClFN2NaO3S | sodium 1-carbamoyl-6-chloro-5-fluoro-3-(thiophene-2-carbonyl)indol-2-olate | sodium 1-carbamoyl-6-chloro-5-fluoro-3-(thiophene-2-carbonyl)indol-2-olate | 360.70 |
| C14H8ClFN2O3S | 6-chloro-5-fluoro-2-hydroxy-3-(thiophene-2-carbonyl)indole-1-carboxamide | Ilonidap | 338.70 |
| C12H15F2NO2 | (2S,3S,5R)-2-(3,5-difluorophenyl)-3,5-dimethyl-morpholin-2-ol | Manifaxine | 243.25 |
| C19H22BrNO4S2 | (9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 2-hydroxy-2,2-bis(2-thienyl)acetate bromide | (9,9-Dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 2-hydroxy-2,2-dithiophen-2-ylacetate;bromide | 472.40 |
| C19H22NO4S2+ | (9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl) 2-hydroxy-2,2-bis(2-thienyl)acetate | SCHEMBL411429 | 392.50 |
| C18H21N3O2 | 3-[(4,7-dimethyl-1,3-benzoxazol-2-yl)methylamino]-5-ethyl-6-methyl-1H-pyridin-2-one | 135525-77-8 | 311.40 |
| C18H24N2O3 | 5-[4-methoxy-3-[(2S)-norbornan-2-yl]oxy-phenyl]hexahydropyrimidin-2-one | 135637-46-6 | 316.40 |
| C18H20ClNOS | (3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine;hydrochloride | DULOXETINE HYDROCHLORIDE | 333.90 |
| C18H19NOS | (3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine | duloxetine | 297.40 |
| C25H25NO4 | N-(3-acetyl-2-hydroxy-phenyl)-4-(4-phenylbutoxy)benzamide | N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide | 403.50 |
| C33H45ClN4O9 | [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-(1-piperidyl)piperidine-1-carboxylate;trihydrate;hydrochloride | Camptosar | 677.20 |
| C33H38N4O6 | [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-(1-piperidyl)piperidine-1-carboxylate | irinotecan | 586.70 |
| C28H42N2O5S | 2-azaniumylethylammonium;(2S,3R)-3-(2-carboxylatoethylsulfanyl)-2-hydroxy-3-[2-(8-phenyloctyl)phenyl]propanoate | 2-azaniumylethylammonium;(2S,3R)-3-(2-carboxylatoethylsulfanyl)-2-hydroxy-3-[2-(8-phenyloctyl)phenyl]propanoate | 518.70 |
| C20H21N5O6 | (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid | (2R)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid | 427.40 |
| C27H34N4O4 | 2-benzamidoacetic acid;4-(dipropylamino)-1,3,4,5-tetrahydrobenzo[cd]indole-6-carboxamide | AC1Q5WNG | 478.60 |
| C18H25N3O | 4-(dipropylamino)-1,3,4,5-tetrahydrobenzo[cd]indole-6-carboxamide | LY 178210 | 299.40 |
| C24H29N5O3 | (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid | valsartan | 435.50 |
| C22H29N5O5S | [4-[3-(ethylamino)-2-pyridyl]piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone;methanesulfonic acid | Atevirdine mesylate | 475.60 |
| C21H25N5O2 | [4-[3-(ethylamino)-2-pyridyl]piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone | Atevirdine | 379.50 |
| C30H33Cl2F2N5O2 | 1-[2-(4-amino-2,6-dichloro-anilino)-2-oxo-ethyl]-4-[5,5-bis(4-fluorophenyl)pentyl]piperazine-2-carboxamide | Draflazine | 604.50 |
| C16H28N5O9-3 | 2-[bis[2-[carboxylatomethyl-[2-(methylamino)-2-oxo-ethyl]amino]ethyl]amino]acetate;hydrate | 138721-73-0 | 434.42 |
| C9H22NNaO7P2 | sodium hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphono-propyl]phosphinate | sodium hydroxy-[1-hydroxy-3-[methyl(pentyl)amino]-1-phosphono-propyl]phosphinate | 341.21 |
| C9H23NO7P2 | [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphono-propyl]phosphonic acid | Ibandronic Acid | 319.23 |
| C21H24Cl2N4O2S | 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one;hydrate;hydrochloride | 138982-67-9 | 467.40 |
| C21H21ClN4OS | 5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one | Ziprasidone | 412.90 |
| C12H20N4O7 | (2R,3R,4S)-3-acetamido-4-guanidino-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid | zanamivir | 332.31 |
| C23H30N4O4S | ethyl 4-methyl-2-[methyl-[4-[(2-methylimidazo[4,5-c]pyridin-1-yl)methyl]phenyl]sulfonyl-amino]pentanoate | DO 6 | 458.60 |
| C16H21N3O2 | (4S)-4-[[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl]oxazolidin-2-one | zolmitriptan | 287.36 |
| C22H28FNO3 | (2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]-4-piperidyl]methanol | 139290-69-0 | 373.50 |
| C8H15ClN2O | N-methoxy-1-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)methanimine;hydrochloride | CI 979; Milameline hydrochloride; PD 129409 | 190.67 |
| C8H14N2O | N-methoxy-1-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)methanimine | CI-979;RU35926 | 154.21 |
| C27H24N4O6 | (2S)-2-[5-[(3-methyl-1-oxo-4H-benzo[f]quinazolin-9-yl)methylamino]-1-oxo-isoindolin-2-yl]pentanedioic acid | (2S)-2-[5-[(3-methyl-1-oxo-4H-benzo[f]quinazolin-9-yl)methylamino]-1-oxo-isoindolin-2-yl]pentanedioic acid | 500.50 |
| C21H24ClNO3 | 2-[11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride | 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride | 373.90 |
| C21H23NO3 | 2-[11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid | (E)-Olopatadine | 337.40 |
| C14H12N6O | 2-[[4-(4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl)phenyl]hydrazono]propanedinitrile | Simendan | 280.28 |
| C23H19N2NaO4S | sodium 5-[[4-[3-(5-methyl-2-phenyl-oxazol-4-yl)propanoyl]phenyl]methyl]-4-oxo-thiazol-2-olate | sodium 5-[[4-[3-(5-methyl-2-phenyl-oxazol-4-yl)propanoyl]phenyl]methyl]-4-oxo-thiazol-2-olate | 442.50 |
| C23H20N2O4S | 5-[[4-[3-(5-methyl-2-phenyl-oxazol-4-yl)propanoyl]phenyl]methyl]thiazolidine-2,4-dione | Darglitazone | 420.50 |
| C20H32N5O8P | [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate | ADEFOVIR DIPIVOXIL | 501.50 |
| C26H33FNNaO5 | sodium (3R,5S)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]-3,5-dihydroxy-hept-6-enoate | sodium (3R,5S)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]-3,5-dihydroxy-hept-6-enoate | 481.50 |
| C26H34FNO5 | (3R,5S)-7-[4-(4-fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]-3,5-dihydroxy-hept-6-enoic acid | RefChem:774307 | 459.50 |
| C33H44N6O5 | (2R)-N-[(1S)-1-benzyl-3-[tert-butylcarbamoyl(isobutyl)amino]-2-hydroxy-propyl]-2-(quinoline-2-carbonylamino)butanediamide | SCHEMBL2773923 | 604.70 |
| C17H26ClN3O2S | N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]ethanesulfonamide;hydrochloride | NARATRIPTAN HYDROCHLORIDE | 371.90 |